-
- Company
Collaboration to focus on cardiovascular diseases and ophthalmology in China
Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals
Bayer and RTW Investments, LP (“RTW”) today announced an equity investment into Ji Xing Pharmaceuticals Limited (“JIXING”) in the amount of USD 35 million and USD 127 million respectively. JIXING, founded and backed by RTW, is a clinical-stage biopharmaceutical company committed to bringing…